Grace Guzman

4.7k total citations · 2 hit papers
113 papers, 3.2k citations indexed

About

Grace Guzman is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Grace Guzman has authored 113 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 29 papers in Surgery and 29 papers in Molecular Biology. Recurrent topics in Grace Guzman's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Liver Disease and Transplantation (7 papers). Grace Guzman is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Liver Disease and Transplantation (7 papers). Grace Guzman collaborates with scholars based in United States, Spain and South Korea. Grace Guzman's co-authors include Scott J. Cotler, Thomas J. Layden, Nissim Hay, Lydia M. Petrovic, Gregorio Chejfec, Elizabeth M. Brunt, Alexander R. Terry, Véronique Nogueira, Jennifer Au and Sang‐Min Jeon and has published in prestigious journals such as Nature Communications, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Grace Guzman

104 papers receiving 3.2k citations

Hit Papers

Hexokinase-2 depletion inhibits glycolysis and induces ox... 2018 2026 2020 2023 2018 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grace Guzman United States 30 1.4k 873 656 496 490 113 3.2k
Haiyan Zhang China 33 1.9k 1.4× 506 0.6× 832 1.3× 390 0.8× 518 1.1× 158 3.7k
Iwata Ozaki Japan 32 1.3k 0.9× 1.3k 1.5× 538 0.8× 838 1.7× 517 1.1× 111 3.7k
Kaori Suzuki Japan 31 1.9k 1.3× 701 0.8× 325 0.5× 608 1.2× 859 1.8× 102 4.0k
You Zhou Finland 30 1.4k 1.0× 1.2k 1.4× 709 1.1× 278 0.6× 236 0.5× 104 3.2k
Yuan Liu China 30 1.3k 1.0× 612 0.7× 716 1.1× 184 0.4× 476 1.0× 162 2.9k
Tõru Nakamura Japan 35 1.2k 0.9× 666 0.8× 476 0.7× 674 1.4× 884 1.8× 215 3.9k
Willscott E. Naugler United States 24 1.6k 1.2× 1.4k 1.6× 843 1.3× 1.0k 2.1× 1.0k 2.1× 42 4.6k
Chiung‐Nien Chen Taiwan 36 1.4k 1.0× 288 0.3× 540 0.8× 321 0.6× 529 1.1× 124 3.4k
Scott Turner United States 39 1.7k 1.2× 957 1.1× 416 0.6× 212 0.4× 369 0.8× 122 4.8k

Countries citing papers authored by Grace Guzman

Since Specialization
Citations

This map shows the geographic impact of Grace Guzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Guzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Guzman more than expected).

Fields of papers citing papers by Grace Guzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Guzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Guzman. The network helps show where Grace Guzman may publish in the future.

Co-authorship network of co-authors of Grace Guzman

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Guzman. A scholar is included among the top collaborators of Grace Guzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Guzman. Grace Guzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, Aaron Philip, Stacie B. Dusetzina, Hannah E. Fuchs, et al.. (2025). Provider billing margin and cancer treatment selection: population based cohort study. BMJ. 391. e084729–e084729.
3.
Xu, Kai, María Dolores Frutos, María Ángeles Núñez‐Sánchez, et al.. (2025). Hepatic HKDC1 deletion alleviates western diet-induced MASH in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167746–167746. 1 indexed citations
4.
Elkhadragy, Lobna, Luke R. Jordan, Nahed Ismail, et al.. (2025). Development of a genetically tailored implantation hepatocellular carcinoma model in Oncopigs by somatic cell CRISPR editing. Disease Models & Mechanisms. 18(1). 2 indexed citations
6.
Liu, Jianjun, et al.. (2023). Deposition of Sevelamer crystals in gastrointestinal tract and lung parenchyma: A rare autopsy finding. American Journal of Clinical Pathology. 160(Supplement_1). S3–S3.
7.
Liao, Xiubei, et al.. (2022). Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1–FOXO1 axis. Oncogene. 41(30). 3778–3790. 19 indexed citations
8.
Pusec, Carolina, Gregory H. Norris, Adam De Jesus, et al.. (2021). Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver. Cellular and Molecular Gastroenterology and Hepatology. 11(5). 1291–1311. 42 indexed citations
9.
Huang, Yuhui, Benjamin V. Park, Yifan Chen, et al.. (2019). Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score–Matched Study. Journal of Vascular and Interventional Radiology. 30(9). 1317–1324. 6 indexed citations
10.
Nogueira, Véronique, Alexander R. Terry, Krushna C. Patra, et al.. (2018). Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nature Communications. 9(1). 446–446. 374 indexed citations breakdown →
11.
Huang, Shuo, Damiano Fantini, Bradley J. Merrill, et al.. (2017). DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer. Cancer Research. 77(23). 6562–6575. 27 indexed citations
12.
Jayawardena, Dulari, Grace Guzman, Ravinder K. Gill, et al.. (2017). Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 313(1). G16–G25. 29 indexed citations
13.
Mathur, Priya, Jessica J. Gierut, Grace Guzman, et al.. (2016). Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer. Molecular Cancer Research. 14(6). 563–573. 22 indexed citations
14.
Kopanja, Dragana, Zebin Wang, Neha Chandan, et al.. (2015). Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features. Journal of Hepatology. 63(2). 429–436. 76 indexed citations
15.
Holterman, Ai‐Xuan L., Grace Guzman, Giamila Fantuzzi, et al.. (2013). Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity. 21(3). 591–597. 71 indexed citations
16.
Wiley, Elizabeth L., et al.. (2011). Marjolin ulcer: an overlooked entity. International Wound Journal. 8(4). 419–424. 26 indexed citations
17.
Gui, Xianyong, Grace Guzman, Paul R. Dobner, & Shrihari S. Kadkol. (2008). Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides. 29(9). 1609–1615. 46 indexed citations
18.
Guzman, Grace, et al.. (2007). A Survey of the Use of Foreign-Purchased Medications in a Border Community Emergency Department Patient Population. Journal of Emergency Medicine. 33(2). 213–221. 21 indexed citations
19.
Cotler, Scott J., Eric R. Kallwitz, Jamie Berkes, et al.. (2007). Diabetes and Hepatic Oxidative Damage Are Associated With Hepatitis C Progression After Liver Transplantation. Transplantation. 84(5). 587–591. 15 indexed citations
20.
Guzman, Grace, Jennifer E. Layden‐Almer, Thomas J. Layden, et al.. (2005). p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Modern Pathology. 18(11). 1498–1503. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026